Among the patients in the csCMV group, we observed that the proportion of IE1-specific CD4+ T cells increased at approximately 36 weeks after infection (0.010% (IQR: 0–0.143) of total CD4+ T cells) (Figure 2a), whereas wCMV-reactive CD4+ and pp65-specific CD8+ T cell proportions increased during the earlier period, approximately 20 weeks (0.012% (IQR: 0–0.020) of total CD4+ T cells) (Figure 2b) and 24 weeks (0.032% (IQR: 0–0.045) of total CD8+ T cells) (Figure 2c) after infection, respectively. This evidence concerns the gene CD8A and infection.